Erik Arrhenius
Impact in
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Biochemistry top 5%
Papers in
-
- Pharmacogenetics and Drug Metabolism 7
- Drug-Induced Hepatotoxicity and Protection 3
-
- Eicosanoids and Hypertension Pharmacology 4
- Journals
- Chemico-Biological Interactions (11 papers)Biochemical Pharmacology (2 papers)Toxicology (1 paper)Acta chemica Scandinavica/Acta chemica Scandinavica. B, Organic chemistry and biochemistry/Acta chemica Scandinavica. A, Physical and inorganic chemistry/Acta chemica Scandinavica. Series B. Organic chemistry and biochemistry/Acta chemica Scandinavica. Series A, Physical and inorganic chemistry (1 paper)Toxicology and Applied Pharmacology (1 paper)
- Partner nations
- Sweden
In The Last Decade
Erik Arrhenius
31 papers receiving 988 citations
Hit Papers
Peers
Comparison fields: 5 of 92
- Pharmacology 295
- Biochemistry 129
- Clinical Biochemistry 102
- Cancer Research 183
- Endocrinology, Diabetes and Metabolism 201
Countries citing papers authored by Erik Arrhenius
This map shows the geographic impact of Erik Arrhenius's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Arrhenius with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Arrhenius more than expected).
Fields of papers citing papers by Erik Arrhenius
This network shows the impact of papers produced by Erik Arrhenius. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Arrhenius. The network helps show where Erik Arrhenius may publish in the future.
Co-authors
The 25 scholars most cited alongside Erik Arrhenius, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Sequential changes in lipid metabolism and the fatty acid profile in liver lipids during fasting and sepsis. | 1990 | 6 |
| 2 | 1980 | 9 | |
| 3 | 1979 | 17 | |
| 4 | 1979 | 19 | |
| 5 | 1978 | 3 | |
| 6 | 1977 | 25 | |
| 7 | 1975 | 35 | |
| 8 | 1972 | 1 | |
| 9 | 1970 | 38 | |
| 10 | Effects on hepatic microsomal N- and C-oxygenation of aromatic amines by in vivo corticosteroid or aminofluorene treatment, diet, or stress. | 1968 | 51 |
| 11 | Carcinogenic amines : some aspects of their metabolism and interaction with microsomal functions of liver cells | 1968 | 3 |
| 12 | 1967 | 169 | |
| 13 | 1965 | 6 | |
| 14 | EFFECTS OF CARCINOGENIC AMINES ON AMINO ACID INCORPORATION BY LIVER SYSTEMS. II. A MORPHOLOGICAL AND BIOCHEMICAL STUDY ON THE EFFECT OF DIMETHYLNITROSAMINE. | 1963 | 36 |
| 15 | The action of thyroid hormones at the cell level Hit paper breakdown → | 1963 | 435 |
| 16 | Effects of carcinogenic amines on amino acid incorporation by liver systems. I. Secondary increase in microsomal activity after aminofluorene treatment. | 1962 | 38 |
| 17 | 1962 | 37 | |
| 18 | 1961 | 14 | |
| 19 | 1960 | 80 | |
| 20 | 1959 | 4 |
About Erik Arrhenius
Erik Arrhenius is a scholar working on Pharmacology, Biochemistry, Cancer Research, Nutrition and Dietetics and Health, Toxicology and Mutagenesis, having authored 31 papers that have together received 1.2k indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (8 papers), Pharmacogenetics and Drug Metabolism (7 papers), Glutathione Transferases and Polymorphisms (4 papers), Genomics, phytochemicals, and oxidative stress (4 papers), Eicosanoids and Hypertension Pharmacology (4 papers), Alcohol Consumption and Health Effects (4 papers), Muscle metabolism and nutrition (3 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). The work is most often cited by research in Pharmacology (295 citations), Biochemistry (129 citations), Clinical Biochemistry (102 citations), Cancer Research (183 citations) and Endocrinology, Diabetes and Metabolism (201 citations). Erik Arrhenius has collaborated with scholars based in Sweden. Frequent co-authors include T. Hultin, Lars Ernster, Olle R. Lindberg, JR Tata, Shona Pedersen, Rune Hedman, Lars Renberg, H. Löw, Peter Magee and Dan Hultmark. Their work appears in journals such as Chemico-Biological Interactions, Biochemical Pharmacology, Toxicology, Acta chemica Scandinavica/Acta chemica Scandinavica. B, Organic chemistry and biochemistry/Acta chemica Scandinavica. A, Physical and inorganic chemistry/Acta chemica Scandinavica. Series B. Organic chemistry and biochemistry/Acta chemica Scandinavica. Series A, Physical and inorganic chemistry and Toxicology and Applied Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.